Nationwide clinical data exchange for the MEDITECH community. ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- Secure Exchange Solutions (SES), part of...
New functionality and partnerships make it easier for clinicians to access crucial information at the point of care and log...
Commvault's cloud platform brings exceptional resilience to healthcare organizations – critical in an era of escalating and non-stop cyber threats...
Commvault offerings help hospitals recover Electronic Health Records, deliver uninterrupted patient care, and meet evolving HIPAA guidelines LAS VEGAS, March...
DENVER, March 3, 2025 /PRNewswire/ -- Affineon Health, a leader in AI inbox automation for healthcare providers, today announces that Commure...
By combining and extending the proven capabilities of Dragon Medical One (DMO) and DAX Copilot (DAX), Dragon Copilot promotes clinician well-being, increases...
Counterpart Health, MEDITECH, and Suki are using Vertex AI Search for healthcare to improve clinicians' access to information and gain...
Groundbreaking intelligence addresses a $1B industry problem, helping healthcare organizations streamline billing workflows and receive accurate reimbursement SAN FRANCISCO, March...
JUNO BEACH, Fla., March 3, 2025 /PRNewswire/ -- Juno Health, a leader in healthcare innovation and digital transformation, is partnering...
Leading the Way in Healthcare Innovation Across the Medication Journey SAN ANTONIO, March 3, 2025 /PRNewswire/ -- DrFirst, a leading...
One of Ohio's largest integrated health systems deploys the 1Clearsense Platform to create a longitudinal EHR, enabling comprehensive access to...
Clearlake to Acquire ModMed from Warburg Pincus BOCA RATON, Fla., March 3, 2025 /PRNewswire/ -- ModMed® (the "Company"), a pioneer in specialty-specific healthcare...
New functionality within Counterpart Assistant uses Google Cloud’s Vertex AI Search to give clinicians comprehensive insights across multiple sources of...
Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter 2025License agreement...
LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx® (secukinumab) treatment in HS...
If approved, daratumumab will be the only anti-CD38 available for all patient types across newly diagnosed multiple myeloma, cementing daratumumab...
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney...
Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product...
Cash and cash equivalents of $131.9M as of December 31, 2024 Cash runway extends through anticipated topline data readouts of...